|
Post by kc on Jan 26, 2018 14:05:56 GMT -5
Now, watch MNKD drop to $0.87 over the next 7 days. I've screwed us all. The aliens have arrived. May I offer you a beverage, drano on ice? New arrivals used to be offered PINK CHAMPAGNE ON ICE. Are things that bad now that we substitute it was drano?
|
|
|
Post by kc on Jan 26, 2018 14:03:02 GMT -5
Before I venture an answer to your last question... explain why you think it likely that good news comes on 29th. MNKD has for years done these sorts of conferences and I don't recall a single time where it was the venue to announce something meaningful. At the conference I expect praising jump in revenue (from price hike), some references to negotiating better insurance coverage, work continuing on finding overseas partners and a teasing mention of RLS (we can never see that Mike winks every time he mentions RLS) Oh, and very quick mumbling under his breath about missing guidance last period. Hmm... what has my experience been so far as MNKD investor... well, there was this time I had a laparoscopic operation that went horribly wrong... or there was when I got caught in a rock slide in the mountains. Can't quite pick the perfect analogy. Is your SO wanting to try Afrezza? "Before I venture an answer to your last question... explain why you think it likely that good news comes on 29th." Geezus, DBC, give the new guy a break! The answer to your question is revealed in his post - in the very first sentence, for goodness sake. Grand man, hang in there, it's going to be a bumpy ride! Yes the good news will come on the 29th of February in a leap year. When is the next leap year?
|
|
|
Post by kc on Jan 26, 2018 11:04:37 GMT -5
Kovacocy. 3 mins ago: - "MNKD - the run is just beginning. Add at $3.10-3.15." This advice from the GREAT SALAMI or SWAMI (you make the call) and $5.00 gets me starbucks coffee today.
|
|
|
Post by kc on Jan 26, 2018 9:51:34 GMT -5
Investors were punked by Adam Fuerstein's comment on Biogen yesterday. didn't know that many people hung on his words. but it shows how one person can manipulate the market with one tweet. The SEC should be sent that tweet but we all know they don't even know which end is up.
|
|
|
Post by kc on Jan 25, 2018 21:10:53 GMT -5
I bet Spencer (for hire) Osborn will hit overnight as will LFD he has been quiet for a bit.
|
|
|
Post by kc on Jan 25, 2018 20:03:43 GMT -5
A substantial increase in the script count tomorrow and one announcement will put a lot of minds at ease. C'mon Castanga, one announcement please! An appointment of Sports to the BOD perhaps? She gets my vote.
|
|
|
Post by kc on Jan 25, 2018 15:12:55 GMT -5
Next offering to International partner for 15% interest at $20.00 per share. Now that would be a shortSqueeze situation. Who did Mike meet with at JPM Healthcare summit. Every dog has his day and sooner or later so will MannKind Shareholders.
|
|
|
Post by kc on Jan 25, 2018 11:36:49 GMT -5
Next offering to International partner for 15% interest at $20.00 per share. Now that would be a shortSqueeze situation.
|
|
|
Post by kc on Jan 24, 2018 22:01:51 GMT -5
I know a couple doctors on the same list in my area. They are good doctors and this is the way this supplement their income by speaking on the half of the Pharma company.
Do the research on doctors who you know in your community I am sure you were fine they have taken some money from big Pharma also.
|
|
|
Post by kc on Jan 24, 2018 21:12:26 GMT -5
Dr. Bode is Will paid by the pharmaceutical industry. Go to this link put his name and you’ll see the figures he was paid in 2016 and 2015. openpaymentsdata.cms.gov/physician/265665/summary2016 payments to Dr. Bode. $460,993 Top Companies Making General Payments SANOFI-AVENTIS U.S. LLC: $141,434.20 JANSSEN PHARMACEUTICALS,...: $102,618.16 NOVO NORDISK AS: $81,869.82 NOVO NORDISK INC: $68,572.03 MEDTRONIC MINIMED, INC.: $38,556.75 ASTRAZENECA...: $12,302.08 MANNKIND CORPORATION: $7,548.47 INSULET CORPORATION: $5,789.67 GLAXOSMITHKLINE, LLC.: $464.66 AMARIN PHARMA INC.: $238.35 2015 payments $648,213 Top Companies Making General Payments SANOFI-AVENTIS U.S. LLC: $244,533.34 JANSSEN PHARMACEUTICALS,...: $113,332.81 NOVO NORDISK INC: $63,014.03 GLAXOSMITHKLINE, LLC.: $57,041.74 NOVO NORDISK AS: $43,194.44 ASTRAZENECA...: $41,856.69 MEDTRONIC MINIMED, INC.: $34,255.93 INSULET CORPORATION: $16,775.94 BECTON, DICKINSON AND...: $13,208.61 BOEHRINGER INGELHEIM...: $6,913.07 Dr. Bode 2015 projects.propublica.org/docdollars/doctors/pid/265665Drugs & Devices in 2015 Totals listed below account for all payments from August 2013 to December 2015 that mention this product. If a payment record mentions more than one product, the entire value will be included in each of those products. PRODUCT NAME PRODUCT TYPE PAYMENTS† INVOKANA Drug $113K TOUJEO Drug $109K AFREZZA Drug $88,143 TANZEUM Drug $56,000 VICTOZA Drug $42,729 LANTUS Drug $36,074 APIDRA Drug $35,942 TRESIBA Drug $33,354 INSULIN PUMP Device $32,047 BYDUREON Drug $23,855 FARXIGA Drug $18,019 OMNIPOD Drug $16,776 GLYXAMBI Drug $7,119 JANUVIA Drug $6,184 JANUMET Drug $6,167 JANUMET XR Drug $6,159 DIABETES CARE Device $6,004 NOVOLOG Drug $5,411 JARDIANCE Drug $4,471 V-GO Device $3,318 CONTINUOUS GLUCOSE MONITOR Device $1,922 INSULIN PUMP INFUSION SETS Device $1,201 INFUSION DEVICE Device $918 T-SLIM INSULIN PUMP Device $483 AIRCRAFT MEDICAL Device $161 METERS Device $117 TRULICITY Drug $116 HUMALOG Drug $116P
|
|
|
Post by kc on Jan 24, 2018 11:42:37 GMT -5
Luara does have that diabetic Mary Tyler Moore, THIN look. just saying. At times, a type one, can just be spotted. I know she plays tennis.. But she probably has a great fitness trainer in Atlanta like LeAnn in CA.
|
|
|
Post by kc on Jan 24, 2018 11:28:07 GMT -5
Dr. Bode is Sam's Doctor. He might also be Laura's Dr. too.
|
|
|
Post by kc on Jan 24, 2018 11:25:47 GMT -5
I’d be content with a New York City burger at this point in time. Not quite sunk to a New York street hotdog then? I had a lobster roll in NYC for $20.00 it was a fast food joint.
|
|
|
Post by kc on Jan 24, 2018 11:24:40 GMT -5
So based on the feedback so far. The share price is based principally on fast food prices. This is good to know. Just inhale your Afrezza when you sit down with your two big Mac's.
|
|
|
Post by kc on Jan 20, 2018 22:52:48 GMT -5
I can’t open with my iPhone but if they have reserved a booth early that is positive since they waited till the last minute in the past. Good for MannKind.
I posted this last week on another thread.
The STAT study is probably being saved for ADA 2018 in Orlando FL.
You then have later that month in Orlando the ADA.... Jun 22 - 26, 2018 | Orlando, Florida
professional.diabetes.org/meeting/scientific-sessions/78th-scientific-sessions
Abstract submission dates:
Abstract Submission Deadlines
Abstract guidelines: professional.diabetes.org/sites/professional.diabetes.org/files/media/2018_late_breaking_abstract_submission_guidelines.pdf
Regular Abstract Submission
October 2, 2017-January 8, 2018
Late Breaking Abstract Submission February 1, 2018-March 12,2018
|
|